| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 6.02% | -35.48% | 29.46% | 52/158 | 1.25% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 4.65% | -33.85% | 29.17% | 34/158 | 0.28% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 3.6% | -5.01% | -66.79% | 26/158 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 10.84% | 5.04% | 16.18% | 26/158 | -9.6% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 9.33% | -4.89% | 32.72% | 29/158 | 4.24% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 7.03% | 14.5% | 85.49% | 23/158 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3.79% | 11.8% | -63.28% | 18/158 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 10.32% | -57.09% | 5.2% | 31/158 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 9.81% | -50.1% | 59.77% | 24/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 6.14% | -61.7% | 81.12% | 26/158 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 3.39% | 2% | -85.9% | 29/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 24.05% | -23.96% | 22.33% | 3/158 | 0.72% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 19.66% | 2% | 22.65% | 2/158 | 2.84% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 16.03% | -14.64% | -49.32% | 2/158 | 2.19% | 小方制药 | 34.81% | 行业排名> |
| 2021-12-31 | 31.63% | -33.31% | 68.42% | 3/158 | 0.79% | 退市金泰 | 10.74% | 行业排名> |
| 2021-06-30 | 18.78% | 2% | -60.4% | 2/158 | 2.97% | ST人福 | 6.82% | 行业排名> |
| 2020-12-31 | 47.43% | 108.12% | 108.12% | 2/158 | 3.66% | 小方制药 | 71.99% | 行业排名> |
| 2019-12-31 | 22.79% | 421.51% | 421.51% | 14/158 | 2.57% | 汇宇制药 | 39.25% | 行业排名> |
| 2018-12-31 | 4.37% | 2% | 2% | 93/158 | 7.17% | 汇宇制药 | 28.14% | 行业排名> |

微信公众号
证券之星APP


